Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Interaction of the Ras-related protein associated with diabetes rad and the putative tumor metastasis suppressor NM23 provides a novel mechanism of GTPase regulation.

Proceedings of the National Academy of Sciences of the United States of America | 1999

Rad is the prototypic member of a new class of Ras-related GTPases. Purification of the GTPase-activating protein (GAP) for Rad revealed nm23, a putative tumor metastasis suppressor and a development gene in Drosophila. Antibodies against nm23 depleted Rad-GAP activity from human skeletal muscle cytosol, and bacterially expressed nm23 reconstituted the activity. The GAP activity of nm23 was specific for Rad, was absent with the S105N putative dominant negative mutant of Rad, and was reduced with mutations of nm23. In the presence of ATP, GDP.Rad was also reconverted to GTP.Rad by the nucleoside diphosphate (NDP) kinase activity of nm23. Simultaneously, Rad regulated nm23 by enhancing its NDP kinase activity and decreasing its autophosphorylation. Melanoma cells transfected with wild-type Rad, but not the S105N-Rad, showed enhanced DNA synthesis in response to serum; this effect was lost with coexpression of nm23. Thus, the interaction of nm23 and Rad provides a potential novel mechanism for bidirectional, bimolecular regulation in which nm23 stimulates both GTP hydrolysis and GTP loading of Rad whereas Rad regulates activity of nm23. This interaction may play important roles in the effects of Rad on glucose metabolism and the effects of nm23 on tumor metastasis and developmental regulation.

Pubmed ID: 10611312 RIS Download

Associated grants

  • Agency: NIDDK NIH HHS, United States
    Id: T32 DK007260
  • Agency: NIDDK NIH HHS, United States
    Id: P30 DK036836
  • Agency: NIDDK NIH HHS, United States
    Id: F32 DK009193
  • Agency: NIDDK NIH HHS, United States
    Id: DK 45935
  • Agency: NCI NIH HHS, United States
    Id: R01 CA037393
  • Agency: NIDDK NIH HHS, United States
    Id: R01 DK047919
  • Agency: NIDDK NIH HHS, United States
    Id: R01 DK045935
  • Agency: NIDDK NIH HHS, United States
    Id: R01 DK 47919
  • Agency: NCI NIH HHS, United States
    Id: R01 CA 37393

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Joslin Diabetes Center Bioinformatics and Biostatistics Core (tool)

RRID:SCR_015092

Core that offers support for data-driven projects related to basic, clinical and translational research, with a particular emphasis on diabetes. The core aims to ensure that researchers take advantage of the most modern and robust methods available in the field of Bioinformatics and Biostatistics.

View all literature mentions

Joslin Diabetes Center Flow Cytometry Core Facility (tool)

RRID:SCR_009878

THIS RESOURCE IS NO LONGER IN SERVICE. Documented on October 27,2023. Core that provides cell sorting and flow cytometry services. Specific services include cell analysis, large object sorting,magnetic cell enrichment, and automatic cell counting.

View all literature mentions

Joslin Diabetes Center Advanced Microscopy Core Facility (tool)

RRID:SCR_009875

THIS RESOURCE IS NO LONGER IN SERVICE. Documented on October 27,2023. Core that provides services for performing specific morphological procedures, providing training and access to equipment, maintaining the specialized microscopes, and giving advice and interpretation.

View all literature mentions

Joslin Diabetes Center Animal Physiology Core Facility (tool)

RRID:SCR_009876

THIS RESOURCE IS NO LONGER IN SERVICE. Documented on October 27,2023. Core that provides technically advanced physiological evaluation of metabolism in diabetes, obesity, and their associated complications in rodents for DRC investigators and outside users. It also provides training of investigators and trainees in several physiological procedures.

View all literature mentions

Joslin Diabetes Center Advanced Genomics and Genetics Core Facility (tool)

RRID:SCR_009873

THIS RESOURCE IS NO LONGER IN SERVICE. Documented on October 27,2023. Core that provides services for genetic and genomic analysis, including DNA extraction from blood, access to DNA collections from the Core?s repository, SNP genotyping, and support for gene expression studies based on both high-density oligonucleotide arrays and real-time quantitative PCR.

View all literature mentions

Joslin Diabetes Center Induced Pluripotent Stem Cell Core (tool)

RRID:SCR_015120

Core that maintains a centralized facility for the generation and propagation of reprogrammed iPS cells for use in molecular and cellular pathologies underlying diabetes and its complications.

View all literature mentions

Joslin Diabetes Center Enrichment Core (tool)

RRID:SCR_015094

Six component core which facilitates the exchange of research information and discussions among investigators, fellows and students within the Joslin Diabetes Center, as well as between Joslin Staff and outside researchers with similar interests.

View all literature mentions